UNITED THERAPEUTICS Corp Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2010 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
UNITED THERAPEUTICS Corp quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2010 to Q4 2023.
  • UNITED THERAPEUTICS Corp Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $30.8M, a 37.5% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $30.8M +$8.4M +37.5% Dec 31, 2023 10-K 2024-02-21
Q4 2022 $22.4M +$10.9M +94.8% Dec 31, 2022 10-K 2024-02-21
Q4 2021 $11.5M -$24M -67.6% Dec 31, 2021 10-K 2023-02-22
Q4 2020 $35.5M -$1.1M -3.01% Dec 31, 2020 10-K 2022-02-24
Q4 2019 $36.6M -$6M -14.1% Dec 31, 2019 10-K 2021-02-24
Q4 2018 $42.6M +$25.7M +152% Dec 31, 2018 10-K 2020-02-26
Q4 2017 $16.9M +$12.2M +260% Dec 31, 2017 10-K 2019-02-27
Q4 2016 $4.7M +$1.3M +38.2% Dec 31, 2016 10-K 2018-02-21
Q4 2015 $3.4M +$419K +14.1% Dec 31, 2015 10-K 2017-02-22
Q4 2014 $2.98M +$474K +18.9% Dec 31, 2014 10-K 2016-02-25
Q4 2013 $2.51M -$3.16M -55.7% Dec 31, 2013 10-K 2015-02-24
Q4 2012 $5.67M +$207K +3.79% Dec 31, 2012 10-K 2014-02-25
Q4 2011 $5.46M -$563K -9.35% Dec 31, 2011 10-K 2013-02-26
Q4 2010 $6.02M Dec 31, 2010 10-K 2012-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.